arrow
D

D. Clark Files

Wake Forest University School of Medicine
H指数:47
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Systematic data capture reduces the need for source data verification: exploratory analysis from a phase 2 multicenter randomized controlled platform trial

系统化数据捕获减少了源数据验证的需求:一项来自一项多中心随机对照平台试验的探索性分析

2025-10-290
OAAI
The circulating renin-angiotensin system and mortality among patients hospitalized for COVID-19: a mechanistic substudy of the ACTIV-4 Host Tissue trials

循环肾素-血管紧张素系统与因COVID-19住院患者的死亡率:ACTIV-4宿主组织试验的一项机制性亚研究

2025-03-010
PRE
Redox Preservation of Blood Specimens
2024-11-010
PRE
Acetaminophen for Prevention and Treatment of Organ Dysfunction in Critically Ill Patients With Sepsis
2024-08-063
OA
Tackling Brain and Muscle Dysfunction in Acute Respiratory Distress Syndrome Survivors NHLBI Workshop Report

解决急性呼吸窘迫综合征幸存者的大脑和肌肉功能障碍NHLBI研讨会报告

2024-06-011
OA
Research Bronchoscopies in Critically Ill Research Participants An Official American Thoracic Society Workshop Report

美国胸科学会官方研讨会报告

2023-05-015
OAAI
Renin-Angiotensin System Modulation With Synthetic Angiotensin (1-7) and Angiotensin II Type 1 Receptor-Biased Ligand in Adults With COVID-19 Two Randomized Clinical Trials

合成血管紧张素 (1-7) 和血管紧张素II 1型受体偏向配体对新型冠状病毒肺炎成人肾素-血管紧张素系统的调节作用两项随机临床试验

2023-04-1121
OA
Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021-April 2022
2022-12-3111
OAAI
Vaccine effectiveness of primary series and booster doses against covid-19 associated hospital admissions in the United States: living test negative design study

在美国,主要系列和加强剂量对新型冠状病毒肺炎相关住院的疫苗有效性: living test阴性设计研究

2022-10-1156
OAAI
Oxygen-Free Days as an Outcome Measure in Clinical Trials of Therapies for COVID-19 and Other Causes of New-Onset Hypoxemia
CHEST
IF8.6
2022-10-0115
OAAI
Tixagevimab-cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase atrial
2022-10-0166
OAAI